European Journal of Internal Medicine
Volume 20, Issue 3 , Pages 242-252, May 2009

Genetic susceptibility to systemic sclerosis:

From clinical aspect to genetic factor analyses

  • Brigitte Granel

      Affiliations

    • INSERM, U906, Marseille, F-13385, France
    • Service de Médecine Interne, Hôpital Nord, Assistance Publique Hôpitaux de Marseille (AP-HM), chemin des Bourrely, 13915 Marseille Cedex 20, France
    • Corresponding Author InformationCorresponding author. INSERM, U906 et Laboratoire de Parasitologie et de Mycologie, Marseille, F-13385, France. Tel.: +33 4 91 32 45 23; fax: +33 4 91 79 60 63.
  • ,
  • Fanny Bernard

      Affiliations

    • INSERM, U906, Marseille, F-13385, France
  • ,
  • Christophe Chevillard

      Affiliations

    • INSERM, U906, Marseille, F-13385, France
    • Laboratoire de Parasitologie et de Mycologie, Faculté de Médecine, Université de la Méditerranée, Marseille, F-13385, France

Received 25 March 2008; received in revised form 18 June 2008; accepted 7 July 2008. published online 15 September 2008.

Abstract 

Background

Systemic sclerosis is a rare autoimmune disease mainly characterized by vascular alteration and fibrosis involving skin but also visceral organs such as lungs, digestive tract, and heart. This disease leads to high morbidity and mortality. Its pathogenesis remains unclear, but recent attention has focus on genetic factors.

Objective

We first recall the main manifestations associated with systemic sclerosis and leading to its diagnosis and prognosis. Then we propose an overview on human genetics studies, as a number of genetic loci have been identified that appear to be associated with the disease.

Methods

Articles concerning association studies with candidate genes encoding for extracellular matrix proteins, cytokines, growth factors, chemokines, and proteins involved in vascular tone and immune regulations are presented and discussed.

Results/conclusion

Systemic sclerosis is a multigenic complex disorder. Genetic associations are observed in distinct phenotypes such as the diffuse cutaneous form or the limited form, or in association with specific autoantibody pattern. Promising candidate genes are those involved in pathways that lead to the vascular damage and fibrosis. A better knowledge of crucial mediators involved in systemic sclerosis could in the future provide new therapeutic strategies to control the disease.

Keywords: Genetic association, Polymorphisms, Systemic sclerosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Please see related article in this issue: localized scleroderma: A series of 52 patients, Toledano C. et al.

PII: S0953-6205(08)00212-4

doi:10.1016/j.ejim.2008.07.012

European Journal of Internal Medicine
Volume 20, Issue 3 , Pages 242-252, May 2009